Phase 2a, open-label, multi-center study evaluating biomarkers and biodistribution of aglatimagene besadenovec plus valacyclovir in men with localized, interme…

Prostate Cancer Patients Treated by RadiotherapyProstate Cancer (Adenocarcinoma)

~Estimated

~$10 – $8,750

Candel Therapeutics, Inc.NCT07332000

Phase 2

Hypofractionated Radiotherapy With a Focal Microboost for High-Risk and Locally Advanced Prostate Cancer

This study is for adult men with previously untreated high risk, very high risk, or pelvic lymph node positive prostate cancer. The purpose of this study is to…

Prostate CancerProstate Cancer Patients Treated by Radiotherapy

~Estimated

~$10 – $6,250

Medical University of South CarolinaNCT07325721